Medical Fish Skin Company Kerecis to Participate in the Biotech Showcase 2023 and the J.P. Morgan Healthcare Conference Read More
$100 Million Financing from LEGO Owner KIRKBI and Others values Medical-Fish-Skin Company Kerecis at $620 million Read More
Atrium Health’s Sanger Heart & Vascular Institute First in the World to Use Implantable Fish-Skin Grafting in Reconstructive Surgery Read More
New Study Finds Statistically Significantly Faster Healing Rates for Diabetic Wound Patients Treated with Kerecis Fish Skin Read More
Medical Fish Skin Company Kerecis Names Gudmundur Oskarsson VP Marketing & Product Management Read More
EY Announces Fertram Sigurjonsson of Kerecis as an Entrepreneur Of The Year® 2021 Mid-Atlantic Award Winner Read More
U.S. Army Institute of Surgical Research Demonstrates Superior Results of Kerecis Omega3 Burn Read More
Clinical Trial Finds Kerecis Omega3 Fish Skin Heals Wounds Significantly Faster than EpiFix Read More
Application of Fish Skin to Open Wounds Improves Healing High-Impact Trial Results of Fish Skin Wound Treatment Presented at Major European Wound Conference Read More
